VNDA·921659108·US·equity·Healthcare - Biotechnology-13D/G
VNDA (VANDA PHARMACEUTICALS INC) is held by 102 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($50.3M), RENAISSANCE TECHNOLOGIES LLC ($26M), STATE STREET CORP ($20.8M). Net institutional sentiment: Mixed.
See how VNDA's score breaks down across 4 SEC sources
Showing 1-20 of 113
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer